Members | Facebook | Twitter
Rhode Island Society of Health System Pharmacists
Triple Therapy or Triple Threat? – Triple Antithrombotic Therapy in Patients with Acute Coronary Syndromes After Percutaneous Coronary Intervention
Pharmacists
Wednesday November 16, 2022
12:00pm to 1:00pm
Live Webinar Registration Details in Confirmation Email
Topics:
Triple Therapy or Triple Threat? – Triple Antithrombotic Therapy in Patients with Acute Coronary Syndromes After Percutaneous Coronary Intervention Rachel L. Meilan, PharmD, PGY1 Pharmacy Resident, Rhode Island Hospital
Members: FREE
Non-Members: $10Please register on-line only. Please do not mail in registrations. Fees are payable at sign-in or online via Paypal Online:http://www.rishp.org. Refund requests must be made by written request and are at the discretion of the RISHP Board of Directors.
Learning Objectives
At the completion of this activity, pharmacists will be able to:
1. Define dual antithrombotic therapy (DAT) and triple antithrombotic therapy (TAT).
2. Identify clinical considerations with antithrombotic management in patients with an indication for anticoagulation undergoing percutaneous coronary intervention (PCI).
3. Summarize literature comparing DAT versus TAT.
4. Recall national and international guideline recommendations on management of triple antithrombotic therapy.
5. Identify factors that influence decision for TAT in high-risk patients.
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based educational activity provides 1.0 live contact hour (0.1 ceus) to participants who meet the requirements for CE. No partial credit is available.
UNIVERSAL ACTIVITY NUMBER (UAN)Pharmacists: 0060-9999-0000-88-L01-P
PROGRAM EVALUATION All participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.
REQUIREMENTS FOR CE CREDIT A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit. CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.
DISCLOSURE No person involved in the planning of this educational activity have any relevant financial relationships to disclose.
RISHP President
For website issues issues, please click here
